Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. - Wikidata - awgldk - TriplyDB

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.

http://www.wikidata.org/entity/Q48184014

about

Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?Stem Cell-Mediated Regeneration of the Adult Brain Neurotrophic factors as a therapeutic target for Parkinson's disease Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier Cell therapy in Parkinson's disease Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them.Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.Mapping human brain activity in vivo Genetic regulatory elements introduced into neural stem and progenitor cell populations.Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?Gene therapy for Parkinson's disease: review and update.Fetal stem cell transplantation: Past, present, and future.Cell therapy and transplantation in Parkinson's disease.Transplantation of fetal cells and tissue: an overview.Differentiation of rhesus adipose stem cells into dopaminergic neurons Stem cell transplantation in neurological diseases: improving effectiveness in animal models Multiple system atrophy: current and future approaches to management Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease.Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.Critical aspects of clinical trial design for novel cell and gene therapies.Cell-based therapies for Parkinson disease—past insights and future potential.Cell transplantation for Parkinson's disease.The Interplay between Alpha-Synuclein Clearance and Spreading Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy Development of stem cell-based therapy for Parkinson's disease.Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum Evidence from clinical trials: can we do better?Cellular transplantation strategies for spinal cord injury and translational neurobiology Positron emission tomography imaging of transplant function.The design of clinical trials for cell transplantation into the central nervous system.Treatment of neurodegenerative diseases with neural cell transplantation.PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice Embryonic stem cells as a cell source for treating Parkinson's disease.Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease.The promise and perils of stem cell therapeutics.Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.

P2860

Q26773485-F507F251-5C66-4C80-8C38-A5A0B9FE9146 Q27024152-7FF4E2F7-B74A-4684-BD79-2B6040D5C7BE Q28072117-767A1F3C-6B3F-4304-82C8-07BF8F52F73F Q28273071-2B8DF940-BECC-4769-AF09-F3BE3BCF7E37 Q30472787-FC93EF1F-DB5A-4EBD-8399-0FA1C629F7F8 Q33212017-C2782FDE-C6EB-4E91-9900-F4E8C8925CDC Q33228402-BFB42162-2376-45CD-ADC2-CE334DA70533 Q33481637-55333C62-4228-4220-BA8C-B80D716AABED Q33565361-E91BCEF7-6958-45BB-BE61-9B25894E86BD Q33582076-E3D1D6C9-EEAC-4AF0-A86E-27D0BD3FEE22 Q33693779-A498A8AF-C092-42A6-B4AA-F2C79690E9FD Q34010954-5674BF77-B00D-4C4A-9F57-10BB4C4D7F48 Q34119491-31A1A6A7-00BD-4AA6-BDB4-0E5A3CAAF062 Q34232844-D9FCAD8C-B64A-4EE6-96A3-6225B4E24002 Q34271005-1EE967D1-EFDA-4C90-98C0-9BB630DEA896 Q34277684-721AB33D-33ED-46CF-9256-F3F6C76C6222 Q34358259-10AFA1CA-9E4D-4F7C-8FD4-CBA8888A5BE2 Q34391064-5D23F4F1-0985-42EB-AA42-CCA12AB02934 Q34409502-1CC20865-F69E-43E1-9FBC-77CAD5250B2B Q34416128-DD1311D6-DD44-4CA2-8823-43A205804663 Q35028568-00120DEA-44F1-4213-91D0-995FE548162A Q35575249-94B031F0-3918-403C-B34E-61B3DEECD467 Q35648168-0375B3B7-10F3-44F5-A7F8-06CB6F24C1F1 Q35664438-86B232B3-4908-48EF-9D35-0BF3DADE193E Q35736662-B6D77464-7A94-42F8-83B2-9C811C92A1F9 Q35806033-70E95205-89CA-4BD8-BAAC-C095DC9E467E Q35833984-6363BE54-0B8D-4672-B65E-E76773EB9077 Q35864178-7831ACE1-1A0C-40C0-BABD-CBB259F5317F Q36025246-D3E134CA-590A-406B-A591-2BDA3C582367 Q36034592-15F701B4-987B-4A2C-9ED6-01794FDA5FEC Q36045358-1C42C172-D6EE-408D-B0FE-89FA3D6206C7 Q36045383-552AF932-4CFF-4348-975B-44AE97576B90 Q36045402-5094399C-FA7F-42F6-8D92-0F404E459E03 Q36045409-B6B6B584-DEB8-45E4-81F6-21B79923195C Q36181195-9195F858-A52D-4E65-AFFD-38A552B2B4B7 Q36218704-DABE7CE7-DF14-4408-99A4-946A37070C40 Q36273378-53537D36-5798-4096-938E-0F2F79DA7EC3 Q36326475-27B2BA91-8283-41C3-BB38-249D550D96DE Q36776231-6DC6498A-25D6-4DA6-A91B-B4EBB8C9810E Q36883776-6FA3ED45-929A-44E0-9B8F-6DDBC97CD875

P2860

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.

http://www.wikidata.org/entity/Q48184014

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年学术文章

@wuu

1994年学术文章

@zh

1994年学术文章

@zh-cn

1994年学术文章

@zh-hans

1994年学术文章

@zh-my

1994年学术文章

@zh-sg

1994年學術文章

@yue

1994年學術文章

@zh-hant

name

Evidence for long-term surviva ...... ogressive Parkinson's disease.

@en

Evidence for long-term surviva ...... ogressive Parkinson's disease.

@nl

type

label

Evidence for long-term surviva ...... ogressive Parkinson's disease.

@en

Evidence for long-term surviva ...... ogressive Parkinson's disease.

@nl

prefLabel

Evidence for long-term surviva ...... ogressive Parkinson's disease.

@en

Evidence for long-term surviva ...... ogressive Parkinson's disease.

@nl

P1433

Q48184014-74F2642D-774A-4800-97C5-3B29088DB5F1

P1476

Q48184014-973ABAFD-1584-4E43-B2FE-0638C335ACD3

P2093

Q48184014-36C9C896-6A49-414D-9866-428035DFB8F6

Q48184014-502E5E8A-545B-40C0-BCBF-EB0297971B5B

Q48184014-5FC6A52F-AF76-4991-8816-33056A81D958

Q48184014-820EE521-6E88-46C9-8867-D5771FD198C2

Q48184014-8850A6A2-EE7D-41FD-B285-0D57C7119C12

Q48184014-D54E7DC8-7C66-4378-BBA6-16128C5C412D

Q48184014-DBD07B57-EC3C-4752-9EA8-CBA67C399BFE

P2860

Q48184014-67AFFF53-884A-4F30-9A09-DE7EA32E5A0B

Q48184014-9FA3AD1E-4D6F-4638-942E-A6AE2C10329B

Q48184014-A68138EF-6C41-4327-9348-42619428DE3C

Q48184014-BEBB1E87-0E11-43FB-80FF-3EF8E765A44C

Q48184014-BF61FF39-5334-49BF-9E2E-1814C011A631

P304

Q48184014-D33B237E-4209-4B01-A81F-6921365AA1C0

P31

Q48184014-2DAF50FF-C011-4B13-8158-F19F40497224

P356

Q48184014-F5F6831A-F9DF-476C-9F1E-C26035965BC8

P433

Q48184014-87E74843-890B-4359-AD9D-36AC21180448

P478

Q48184014-7F10C25D-8A85-4DC0-BC24-C19725A03DEF

P50

Q48184014-3EC02B47-F90E-4D69-85C8-076242100DE0

Q48184014-C9590F57-3323-4DF3-8E75-3A9099274FB8

Q48184014-E7B3DE5C-6274-4728-BD0E-8B3A315C48B4

P577

Q48184014-2F6429C6-82FD-429A-9AD8-5E9EF0DC3E0F

P698

Q48184014-D1E17F61-7C79-48B9-BAF9-0996662ADD4B

P921

Q48184014-0B6A57D3-B5DB-4C44-A2AF-B5587B43272D

Q48184014-BF9586C8-7F42-4FEC-800E-F5860B8776EF

P356

P1433

Annals of Neurology

P1476

Evidence for long-term surviva ...... ogressive Parkinson's disease.

@en

P2093

Brooks D

http://www.w3.org/2001/XMLSchema#string

Brundin P

http://www.w3.org/2001/XMLSchema#string

Lindvall O

http://www.w3.org/2001/XMLSchema#string

Odin P

http://www.w3.org/2001/XMLSchema#string

Rothwell JC

http://www.w3.org/2001/XMLSchema#string

Sawle G

http://www.w3.org/2001/XMLSchema#string

Widner H

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons.

The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants.

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.

Transplantation of embryonic dopamine neurons: what we know from rats.

P304

172-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.410350208

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Richard S. J. Frackowiak

Anders Björklund

P577

1994-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8109898

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease